Successful use of uridine triacetate (Vistogard) three weeks after capecitabine in a patient with homozygous dihydropyrimidine dehydrogenase mutation: A case report and review of the literature
Year: 2017
Type: article
Study design: Case Report
Authors: Mira Zurayk, Yi-Kong Keung, David Yu, Eddie HL Hu
Institutions: Huntington Hospital, University of California, Los Angeles
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2756834112
